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DObjectives: The Cox maze IV procedure has the best results for the surgical treatment of atrial fibrillation. It has
been traditionally performed through sternotomy with excellent outcomes, but this has been considered to be too
invasive. An alternative approach is to perform a less invasive right anterolateral minithoracotomy. This series
compared these approaches at a single center in consecutive patients.
Methods: Patients undergoingaCoxmaze IVprocedure (n¼ 356)were retrospectively reviewed fromJanuary2002
to February 2014. Patients were stratified into 2 groups: right minithoracotomy (RMT; n ¼ 104) and sternotomy
(ST; n ¼ 252). Preoperative and perioperative variables were compared as well as long-term outcomes. Patients
were followed up for 2 years and rhythm was confirmed with an electrocardiogram or prolonged monitoring.
Results: Freedom from atrial tachyarrhythmias off antiarrhythmic drugs was 81% and 74% at 1 and 2 years,
respectively, using an RMT approach and was not significantly different from the ST group at these same
time points. The overall complication rate was lower in the RMT group (6% vs 13%, P ¼ .044) as was
30-day morality (0% vs 4%, P ¼ .039). Median length of stay in the intensive care unit was lower in the
RMT group than in the ST group (2 days [range, 0-21 days] vs 3 days [range, 1-61 days]; P ¼ .004) as was
median hospital length of stay (7 days [range, 4-35 days] vs 9 days [range, 1-111 days]; P<.001).
Conclusions: The Cox maze IV procedure performed through a right minithoracotomy is as effective as
sternotomy in the treatment of atrial fibrillation. This approach was associated with fewer complications,
decreased mortality and decreased length of stay in the intensive care unit and hospital length of stay. (J Thorac
Cardiovasc Surg 2014;148:955-62)Atrial fibrillation (AF) is the most common cardiac
arrhythmia with an estimated prevalence of 2.7 to 6.1
million people in the United States. This prevalence is
projected to increase to 5.6 to 12.1 million people in the
United States by themiddle of the century.1 AF is associated
with significant morbidity resulting from loss of
synchronous atrioventricular contraction and the need for
anticoagulation. Despite anticoagulation, AF has been
implicated in up to 15% of all thromboembolic strokes.2
The Cox maze procedure was developed in 1987 in an effort
to surgically treat AF.3-5 After several modifications, the
Cox maze III (CMIII) procedure became the gold
standard for surgical treatment of AF during the 1990s.e Division of Cardiothoracic Surgery, Washington University School of
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The Journal of Thoracic and CaThis technique was performed by median sternotomy and
involved extensive cut-and-sew lesions in both the left
and right atria. Despite its proven efficacy,6-8 the CMIII
did not gain widespread acceptance because of its
technical difficulty and complexity.
The incorporation of new ablation technology has
obviated the need for the traditional cut-and-sew technique
of the CMIII without sacrificing efficacy.9 The Coxmaze IV
(CMIV) procedure, the latest iteration of the procedure,
uses bipolar radiofrequency (RF) and cryoablation to
significantly reduce the operative and crossclamp times,
as well as the complexity of surgical ablation compared
with the traditional cut-and-sew CMIII.10 The simplifica-
tion of replacing surgical incisions with ablation lines has
made the procedure easier to perform and has contributed
to the significant increase in the number of AF surgical
procedures in North America.11,12
In an effort to further reduce operative morbidity, our
group has developed a minimally invasive procedure
involving a full CMIV lesion set through a 5- to 6-cm right
minithoracotomy approach.13,14 Although early results are
promising, the long-term outcomes of this approach
have yet to be evaluated.13 The goal of this series was to
directly compare perioperative and late outcomes between
sternotomy (ST) and right minithoracotomy (RMT)
approaches in a consecutive group of patients undergoing
a CMIV procedure.rdiovascular Surgery c Volume 148, Number 3 955
Abbreviations and Acronyms
AAD ¼ freedom from atrial tachyarrhythmia off
antiarrhythmic drugs
AF ¼ atrial fibrillation
ATA ¼ atrial tachyarrhythmia
CCM ¼ continuous cardiac monitoring
CMIII ¼ Cox maze III
CMIV ¼ Cox maze IV
CPB ¼ cardiopulmonary bypass
ECAS ¼ European Cardiac Arrhythmia Society
ECG ¼ electrocardiogram
EHRA ¼ European Heart Rhythm Association
HRS ¼ Heart Rhythm Society
ICU ¼ intensive care unit
LA ¼ left atrial
LOS ¼ length of stay
LVEF ¼ left ventricular ejection fraction
MVR ¼ mitral valve replacement
PVD ¼ peripheral vascular disease
PVI ¼ pulmonary vein isolation
RA ¼ right atrial
RF ¼ radiofrequency
RMT ¼ right minithoracotomy
ST ¼ sternotomy
STS ¼ Society of Thoracic Surgeons
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DMETHODS
This study was approved by the Washington University School of
Medicine Institutional Review Board. Informed consent and permission
for release of information was obtained from each participant. All data
were entered prospectively into the Society of Thoracic Surgeons (STS)
database or a longitudinal database designed by our institution.
Study Design
Three hundred fifty-six patients who underwent a CMIV as a
stand-alone procedure or with a concomitant mitral procedure from
January 2002 to February 2014 were retrospectively reviewed. Patients
were considered for a corrective arrhythmia procedure if they met the
indications for surgical ablation defined by the recent consensus
statement.15 Concomitant aortic valve procedures and coronary artery
bypass procedures were excluded. Patients were divided into 2 groups
based on the operative approach and compared. The surgical technique
used to perform a minimally invasive CMIV through an RMT has been
previously described by our group.14,16 A non–rib-spreading technique
was used to create a 5- to 6-cm thoracotomy. Femoral cannulation and
direct aortic crossclamping was performed. A 5-mm 30 endoscope was
placed through a separate port through the fifth intercostal space to aid in
visualization and minimize the need for chest wall retraction. Major
differences between right atrial (RA) lesion sets included the replacement
of the right atriotomy performed in the ST approach with a line of bipolar
RF ablation in the RMT approach. All other RA lesions were identical
between the 2 approaches and were accomplished in the RMT approach
by placing either 1 jaw of the bipolar RF clamp or a cryoprobe through 3
separate purse-string sutures placed along the RA. The left atrial (LA)
lesion sets were also similar with the exception that left pulmonary vein
isolation (PVI) was achieved endocardially with sequential cryoablation956 The Journal of Thoracic and Cardiovascular Surgaround the left pulmonary veins (Figure 1). In the RMT group, the LA
appendage was excluded by oversewing from the endocardial surface as
opposed to epicardial excision, which was performed in the ST approach.
Contraindications to an RMT approach included a previous right
thoracotomy, severe atherosclerotic disease of the aorta, iliac, or femoral
vessels, and severely decreased left ventricular ejection fraction (LVEF
20%). All patients scheduled to have an RMT underwent a computed
tomography angiogram of the thoracic and abdominal aorta as well as
the femoral arteries if they were more the 50 years of age, had risk factors
for the development of peripheral vascular disease (PVD), or had evidence
of PVD on physical examination.
All lesionswithin each groupwere similarwith the exception of the addi-
tion in 2005 of a superior LA bipolar RF lesion that connected the superior
left and right pulmonary veins. The addition of this lesionwas added to elec-
trically isolate the entire posterior LA and completed the box lesion set.17
Patients were discharged on class I or III antiarrhythmic drugs and
warfarin, unless contraindicated; antiarrhythmic agents were discontinued
2 months postoperatively if patients were in normal sinus rhythm. Calcium
channel blockers or b-blockers were not considered as antiarrhythmic
drugs.
Sixteen preoperative and 18 perioperative variables were compared
between the groups (Tables 2 and 3) and were chosen based on their
clinical significance or a preliminary analysis of more than 400 variables
collected between the STS databases and our institutional AF database.
Complications including pneumonia, mediastinitis, need for intra-aortic
balloon pump, permanent stroke, reoperation for bleeding, and renal failure
requiring dialysis were considered major complications and compared
between groups. The overall major complication rate was defined as the
aggregate of these complications and compared between groups.
Follow-up
Patients were followed prospectively and had an electrocardiogram
(ECG) at each follow-up visit. In accordance with the 2006 Heart Rhythm
Society (HRS)/European Heart Rhythm Association (EHRA)/European
Cardiac Arrhythmia Society (ECAS) consensus statement on catheter
and surgical ablation of AF, 24 hours of continuous cardiac monitoring
(CCM), which included 24-hour Holter monitoring, pacemaker interroga-
tion, and interrogation of continuous cardiac loop recorders, was obtained
at 3, 6, 12, and 24 months.15 Both overall freedom from atrial tachyarrhyth-
mias (ATAs) and freedom from ATAs off antiarrhythmic drugs (AADs)
were calculated. Success at 1 or 2 years was defined as freedom from
AF, atrial flutter, or atrial tachycardia while off AADs as assessed from
the end of a 3-month blanking period as defined in the HRS/EHRA/
ACAS consensus statements.15,18 Follow-up was available in 95% of
patients. At 1 and 2 years after surgery, follow-up was obtained in 77%
and 58% of patients, respectively. Of the patients who were available for
follow-up, CCM was obtained in 66% at 1 year and 77% at 1 year after
2007. Mean follow-up time was 2.8  2.5 years.
Statistical Analysis
Continuous variables were expressed as themean standard deviation or
the median with the range. Categorical variables were expressed as
frequencies and percentages with outcomes compared using the c2 or the
Fisher exact test. Continuous outcomes were compared using the t test for
means of normally distributed continuous variables and the Mann-Whitney
U nonparametric test for skewed distributions. All data analyses were
performed using SYSTAT 13 software (Systat Software, Inc, Chicago, Ill).
RESULTS
Demographics
A total of 104 patients (29%) underwent a CMIV
procedure through an RMT and 252 patients (71%)
underwent CMIV through a sternotomy approach. Of theery c September 2014
FIGURE 1. A, Cox maze IV left atrial lesion set as performed through a sternotomy. All ablation lines are performed with a bipolar radiofrequency clamp
except for an endocardial cryoablation at the mitral annulus and an epicardial cryoablation over the coronary sinus. B, Cox maze IV left atrial lesion set as
performed through a right minithoracotomy. Reprinted with permission from Bioperspective.
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DRMT group, 54 patients (52%) underwent a concomitant
procedure and 141 patients (56%) in the sternotomy group
underwent a concomitant procedure (Table 1). Among
RMT patients undergoing a concomitant procedure, mitral
valve repair and replacement were performed in 76%
(41/54) and 24% (13/54) of patients, respectively. Among
sternotomy patients undergoing a concomitant procedure,
mitral valve repair and replacement were performed in
51% (74/143) and 46% (67/143) of patients, respectively.
Among the 16 preoperative and 18 perioperative
variables collected (Table 2), there were no significant
differences between the RMT and sternotomy groupsFIGURE 2. A, Overall freedom from ATAs. B, Freedom from ATAs of
The Journal of Thoracic and Cawhen comparing age, gender, AF duration, number of
patients in persistent or long-standing persistent AF,
number of patients with New York Heart Association class
III or IV symptoms, failed catheter ablations, number of
patients with a preoperative pacemaker, or patients with
history of PVD, stroke, chronic lung disease, renal failure,
or dialysis. There were significant differences between the
RMT and sternotomy groups when comparing patients
with paroxysmal AF (RMT, 45% [47 of 104] vs ST, 32%
[81 of 252]; P ¼ .02), LVEF (RMT, 56%  10% vs
ST, 52%  12%; P ¼ .002), and LA diameter (RMT,
4.7  1.0 cm vs ST, 5.3  1.0 cm; P<.001).f AADs. ATA, Atrial tachyarrhythmia; RMT, right minithoracotomy.
rdiovascular Surgery c Volume 148, Number 3 957
TABLE 3. Perioperative data
Variable
RMT
(n ¼ 104)
ST
(n ¼ 252)
P
value
Concomitant procedure, n (%) 54 (52) 143 (57) .487
Mitral valve repair, n (%) 41 (39) 74 (29) .065
Mitral valve replacement, n (%) 13 (13) 67 (27) .004
Box lesion, n (%) 100 (96) 212 (84) .002
Perfusion time (min) 184  41 156  45 <.001
Crossclamp time (min) 82  33 68  33 .001
Early ATA, n (%) 52 (50) 147 (58) .150
Permanent PM, n (%) 7 (7) 22 (9) .531
Overall major complication, n (%) 6 (6) 33 (13) .044
Pneumonia, n (%) 3 (3) 19 (8) .097
Mediastinitis, n (%) 0 (0) 2 (1) .362
Intra-aortic balloon pump, n (%) 0 (0) 5 (2) .148
Permanent stroke, n (%) 0 (0) 2 (1) .362
Reoperation for bleeding, n (%) 2 (2) 7 (3) .640
Renal failure requiring dialysis, n (%) 1 (1) 9 (4) .175
Median ICU LOS, d (range) 2 (0-21) 3 (1-61) .004
Median hospital LOS, d (range) 7 (4-35) 9 (1-111) <.001
30-d mortality, n (%) 0 (0) 10 (4) .039
RMT, Right minithoracotomy; ST, sternotomy; ATA, atrial tachyarrhythmia;
PM, pacemaker; ICU, intensice care unit; LOS, length of stay.
TABLE 1. Concomitant procedures
Operation RMT (n ¼ 54) ST (n ¼ 143)
CMIV þ MV repair 38 58
CMIV þ MV repair þ TVR 3 16
CMIV þ MVR 12* 57y
CMIV þ MVR þ TVR 1 10*
CMIV þ other 0 2z
Aortic valve or coronary bypass procedures were excluded. RMT, Right minithoracot-
omy; ST, sternotomy; CMIV, Cox maze IV; MV, mitral valve; TVR, tricuspid valve
repair;MVR, mitral valve replacement. *Includes 1 LA reduction. yOther procedures
included 1 implantation of a right ventricular assist device and 1 septal myectomy.
zOther procedures included 1 anomalous right carotid artery repair and 1 left anterior
descending artery fistula repair.
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Eighteen perioperative variables were compared between
the RMT and sternotomy groups (Table 3). There were no
significant differences between groups when comparing
the number of concomitant procedures. The ST group did
have a higher percentage of patients who underwent mitral
valve replacement (27% [67 of 252] vs 13% [13 of 104];
P ¼ .004) but there was no difference between patients
who underwent mitral valve repair between groups (29%
[74 of 252] vs 39% [41 of 104]; P¼ .065). The RMT group
had a higher percentage of box lesions performed (96%
[100 of 104] vs 84% [212 of 252]; P<.001). Cardiopulmo-
nary bypass (CPB) time was longer among the RMT group
(184  41 minutes vs 156  45 minutes; P<.001) as was
crossclamp time (82  33 minutes vs 68  33 minutes;
P ¼ .001). The presence of early tachyarrhythmias and
the need for a permanent pacemaker within 30 days was
not different between the groups. Overall major complica-
tions were significantly lower in the RMT group (6%TABLE 2. Preoperative demographics
Variable
RMT
(n ¼ 104)
ST
(n ¼ 252)
P
value
Age (y) 60  11 62  12 .355
Male gender, n (%) 55 (53) 147 (58) .345
AF duration, y* 4 (0.03-37) 4 (0.02-35) .852
Paroxysmal AF, n (%) 47 (45) 81 (32) .020
Persistent AF, n (%) 7 (7) 30 (12) .146
Long-standing persistent AF, (%) 49 (47) 139 (55) .167
NYHA class III or IV, n (%) 49 (47) 137 (54) .213
LVEF (%) 56  10 52  12 .002
Failed catheter ablation, n (%) 28 (27) 66 (26) .887
Preoperative PM, n (%) 11 (11) 32 (13) .646
LA diameter (cm) 4.7  1.0 5.3  1.0 <.001
Chronic lung disease, n (%) 23 (22) 42 (17) .223
Peripheral vascular disease, n (%) 12 (12) 18 (7) .175
Stroke, n (%) 5 (5) 26 (10) .094
Renal failure, n (%) 2 (2) 4 (2) .821
Dialysis, n (%) 1 (1) 0 (0) .119
RMT, Right minithoracotomy; ST, sternotomy; AF, atrial fibrillation; NYHA, New
York Heart Association; LVEF, left ventricular ejection fraction; PM, pacemaker;
LA, left atrial. *Median (min, max).
958 The Journal of Thoracic and Cardiovascular Surg[6 of 104] vs 13% [33 of 252]; P ¼ .044), whereas
individual major complications were not significantly
different when compared individually between groups.
Median length of stay (LOS) in the intensive care unit
(ICU) was significantly reduced among the RMT group
(2 days [range, 0-21 days] vs 3 days [range, 1-61 days];
P< .004) as was median hospital LOS (7 days [range,
4-35 days] vs 9 days [range, 1-111 days]; P < .001).
Thirty-day mortality was significantly lower for the RMT
group (0% [0 of 104] vs 4% [10 of 252]; P ¼ .039).
Freedom From Atrial Tachyarrhythmias
Overall freedom fromATAs among patients undergoing a
CMIV through an ST approach at 3, 6, 12, and 24 months
was 91%, 89%, 86% and 86%, respectively; freedom
from ATAs off AADs was 62%, 75%, 74%, and 79%,
respectively. Overall freedom from ATAs among patients
undergoing a CMIV through an RMT approach at 3, 6,
12, and 24 months was 92%, 92%, 91%, and 83%,
respectively; freedom from ATAs off AADs was 62%,
86%, 81%, and 74%, respectively. There were no
significant differences in freedom from ATAs off AADs
between the sternotomy and RMT groups at any time point
except at 6 months when RMT demonstrated greater
freedom from ATAs off AADs (86% vs 75%; P ¼ .04)
(Figure 2). Separating patients who only had a box lesion
performed (n¼ 312; ST, 212; RMT, 100), overall freedoms
from ATAs at 3, 6, 12, and 24 months were 93%, 98%,
89%, and 89%, respectively for the ST group and 92%,
93%, 90%, and 82% for the RMT group without
significant differences between the groups at each timeery c September 2014
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subgroups were 67%, 91%, 81%, and 83% for the ST
group and 60%, 87%, 82%, and 73% for the RMT group
without significant differences between the groups at each
time point.
DISCUSSION
Advances in minimally invasive techniques over the last
decade have allowed for the development of minimally
invasive approaches for aortic and mitral valve surgery.19,20
In particular, the RMTapproach for mitral valve repair and/
or replacement has shown significant advantages over the
traditional sternotomy approach.21 These same advances
in both technique and technology have allowed CMIV to
be performed through a 5- to 6-cm RMT through the
fourth intercostal space. Our approach has been described
previously and involved femoral cannulation and a non–
rib-spreading technique. An endoscope was used to aid in
visualization and prevent any chest wall retraction.13,14,16
In order to examine the effect of an RMT approach on
arrhythmia procedures for AF, we examined our consecu-
tive series of patients undergoing CMIV with or without
mitral/tricuspid procedures between 2002 and 2014. Cases
of both lone and concomitant surgical ablation were
included to expand the number of patients in each group.
Previous work from our group has shown that the outcomes
of CMIV were similar in patients undergoing either lone
procedures or concomitant ablation in those undergoing
mitral valve surgery, making this a legitimate grouping.22
The percentages of patients undergoing concomitant
procedures were similar in the ST and RMT groups.
Preoperative variables compared between groups showed
that both groups were similar with the exceptions of LA
diameter, the percentage of patients with paroxysmal AF,
and LVEF. The percentage of patients with paroxysmal
AF was 13% greater in the RMT group, however the
percentage of patients with either persistent or long-
standing persistent AF was not significantly different.23
Thus, it is unlikely that the increase in the percentage of
patients with paroxysmal AF had a significant impact on
the observed efficacy using an RMT approach.
LA diameter, another known predictor of recurrence, was
also increased in the sternotomy approach.23 Although
significant, the mean difference in LA size was small in
this study (0.6 cm). Plotting the mean atrial sizes seen in
this study on previously published logistic regression curves
from our group comparing LA size to probability of
recurrence after a CMIV procedure revealed a marginal
increase in the probability of AF of only 2% to 3%.23
Thus, the difference between LA diameters seen in this
study likely had little influence on our results. LVEF was
significantly lower in the ST group, which was expected
given that a severally decreased LVEF excluded patients
from the RMT group. Because this group is at a higherThe Journal of Thoracic and Carisk for perioperative complications, we felt that antici-
pating potential complications that can be treated promptly
through a sternotomy exposure outweighed the benefits
afforded by an RMT approach. Otherwise, all other
preoperative variables, including age and duration of AF,
known predictors of late recurrence, were similar between
groups.23
Because there was a higher percentage of box lesions
performed in the RMT group, a subanalysis of patients
who only received a box lesion was performed. This
subanalysis showed that, at all time points, there was no
difference in overall freedom from ATAs or freedom from
ATAs without AADs between the ST and RMT groups. It
is for these reasons that we believe comparisons between
groups, particularly when discussing efficacy, are valid.
This study demonstrated that a CMIV procedure
performed through an RMT is equally efficacious in curing
AF when compared with a sternotomy after 2 years of
follow-up.14,16 In this series, the freedom from ATAs
while off AADs was 81% at 1 year when performed
through an RMT compared with 74% when performed
through a sternotomy. This efficacy was maintained while
reducing major complications, mortality, ICU LOS, and
hospital LOS compared with a traditional sternotomy
approach. The RMT approach was efficacious and safe in
this selected group of patients.
The only major change to the traditional CMIV lesion set
when performing an RMT approach is that the completion
of the left pulmonary vein and posterior left atrium isolation
was performed using sequential endocardial cryoablations
behind the left pulmonary veins instead of 2 connecting
lines to the previously performed left PVI using bipolar
RF ablation. This change did not seem to alter freedom
from ATAs when comparing the 2 approaches. An RMT
approach did result in increased CPB times and aortic
crossclamp times compared with sternotomy. However,
these differences are marginal; the mean differences were
28 minutes and 14 minutes, respectively. Despite these
slightly longer operative times, there was a significant
decrease in the complication rate and hospital LOS
indicating that the acute outcomes of an RMT approach
are at least noninferior to an ST approach in the periopera-
tive setting (Table 3).
To date, there has been no clear consensus on what
defines a minimally invasive surgical approach to AF.
Most descriptions of minimally invasive surgical attempts
to correct AF have included limited lesion sets including
PVI alone and have been performed either thoracoscopi-
cally or using a minithoracotomy or mini-sternotomy.24-27
We chose an RMT approach because it allowed us access
to both atria while accommodating a bipolar RF clamp,
which has previously been shown to be the most reliable
device experimentally in creating transmural lesions.28,29
Moreover, we feel strongly that a full biatrial lesion setrdiovascular Surgery c Volume 148, Number 3 959
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strated both in large case series and meta-analyses.30,31 A
full Cox maze lesion set requires CPB to reliably create
the lesion set, particularly the right and left atrial isthmus
ablations. Thus, it seemed logical to adopt the same
approach as we have used for minimally invasive mitral
surgery.
Others have described their minimally invasive concom-
itant mitral valve experience, but few groups have reported
long-term follow-up data. Jeanmart and colleagues25
reported their 1-year outcomes after performing a
concomitant unipolar RF endocardial ablation and mitral
valve procedure through an RMT exposure for patients in
AF. This extended lesion set consisted of unipolar
endocardial pulmonary vein isolation with an additional
lesion to the mitral annulus. Overall freedom from AF in
their study was 70%, which included patients receiving
antiarrhythmics. Furthermore, the success rate was likely
overestimated because follow-up consisted only of ECG
and symptoms, but not CCM. In our study, we followed
the recommendations of the most recent consensus state-
ment in terms of both follow-up monitoring and definitions
of recurrent ATAs and report a significantly better freedom
from ATAs, which is likely attributed to the performance of
the CMIV lesion set and the use of the bipolar RF ablation
clamp.
Limitations
This study has several important limitations. This was a
retrospective review, which introduced several potential
biases that could have potentially been avoided if the study
was performed in a prospective fashion. However, these
effects are tempered to some extent because data were
collected prospectively and this was a consecutive series
of patients. Second, there were several differences between
the groups that need to be taken into account. Of the
preoperative variables compared, there were significant
differences in the percentage of patients with paroxysmal
AF, LVEF, and LA diameter between the groups. However,
for reasons mentioned earlier, this likely had minimal
influence on the observed efficacy between the 2
approaches.23 However, it should noted that there were
other variables, such as atherosclerotic burden and frailty,
which were difficult to quantify and may have biased
patient selection. Thus, the finding of decreased morbidity
and mortality among the RMT group might be a representa-
tion of a healthier preoperative status. Nevertheless,
efficacy was equivalent between the 2 groups, suggesting
that a minimally invasive approach can be used in selected
patients without compromising the late restoration of sinus
rhythm. Third, the range of hospital LOS was large for the
ST group (1-111 days). We did choose to include 1 patient
who received a right ventricular assist device for
postcardiotomy shock, however this patient died after960 The Journal of Thoracic and Cardiovascular Surgonly 2 hospital days and was not considered an outlier. It
was because of this large range that we chose to report
LOS not as a mean, which would be influenced by outliers,
but as a median to more accurately represent the LOS for a
given approach. This study does not address the learning
curve for an RMT approach. A preliminary analysis of
CPB times and crossclamp times showed no difference
between groups when comparing patients at the
beginning of the study period and the end of the study
period. However, all procedures were performed by our
institution’s expert maze surgeon who has several
years experience performing minimally invasive RMT
procedures. Thus, our experience is unlikely to represent
a typical learning curve.CONCLUSIONS
The CMIV procedure, when performed through an RMT,
is an effective approach for the surgical treatment of AF and
is noninferior to an ST approach. This minimally invasive
RMT approach, when performed in appropriately selected
patients, resulted in a decrease in major complications,
operative mortality, ICU LOS, and hospital LOS compared
with an ST approach. Freedom from ATAs off AADs
using an RMT approach was similar to an ST approach at
1 and 2 years.References
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Dr Vinay Badhwar (Pittsburgh, Pa). I want to first announce
that Dr Lawrance is a PGY2 and he should be congratulated on
an excellent presentation.
Dr Lawrance and colleagues at Washington University provide
us with an excellent review of their experience with 252 Cox maze
IV operations performed via sternotomy compared with 104 per-
formed via a rib-sparing, video-assisted right minithoracotomy
for the surgical treatment of atrial fibrillation between 2002 and
2014. You and your colleagues are to be commended for teaching
us so much in this field and your continued leadership.
To corroboratively frame your study’s findings, at The Center
for Atrial Fibrillation at the University of Pittsburgh, we share
your embrace of nearly the identical minimally invasive approach
to the Cox maze IV with similar results.
I have 2 questions. Your study design is a retrospective cohort
analysis to really detect noninferiority betweenminimally invasive
and sternotomy approaches for the Cox maze IV. In order to
approximate similarity between the groups, in the manuscript,
instead of a multivariable regression or perhaps a propensity score
analysis, you elected to apply only 12 preoperative variables for a
univariate comparison. It seems that the sternotomy group had
larger atria, lower ejection fraction, more mitral valve replace-
ments, more tricuspid valve operations, less paroxysmal atrial
fibrillation, and a trend toward more persistent atrial fibrillation.
This suggests that the sternotomy group may have a higher
comorbid profile.
Although the longitudinal AF outcome comparison between
minithoracotomy and sternotomy Cox maze seems to be valid
and equally excellent, perhaps the acute outcome comparisons
of 30-day mortality, morbidity, and ICU time may be less fair
without a multivariable or propensity score analysis between
groups. Why were only 12 preoperative variables used in your
comparison?
Dr Lawrance. Thank you, Dr Badhwar, for the excellent
question. More than 400 variables from the STS database and
our custom longitudinal database were recorded on all patients.
We performed a preliminary analysis of these results, and chose
to perform a formal statistical analysis on variables that were either
clinically significant or appeared to be statistically.
Since the time of submission of our abstract, we have actually
included 5 additional variables in our preoperative analysis
including stroke, peripheral vascular disease, chronic lung disease,
renal failure, and dialysis. As we have shown in our presentation,
there were no additional differences between groups when
including these variables.
Despite these similarities, the 2 groups may still be different and
a proper comparison could only be performed in the setting of a
randomized trial. Here we simply present the data from our study.rdiovascular Surgery c Volume 148, Number 3 961
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DDr Badhwar. As the senior author knows very well, the evi-
dence-based mission in surgical education for atrial fibrillation
treatment is really to encourage more surgeons to perform surgical
ablation, particularly the Cox maze IV procedure, when AF exists
at the time of a structural operation.
For some surgeons, early in the learning curve, transitioning
from sternotomy to minimally invasive thoracotomy for isolated
mitral operations, occasionally the existence of atrial fibrillation
and the need to perform a maze procedure may be a nonstarter
and pose a potential obstacle either to abort a minimally invasive
approach for the mitral operation or perhaps cause them to perform
fewer lesions in a non–evidence-based manner.
It seems that the value of this important paper is to support the
principles outlined by others, that a full Cox maze IV lesion set is
indeed possible via a minithoracotomy approach and noninferior
to a sternotomy. What did your group find was the case number
learning curve for the effective performance and application of a
right minimally invasive Cox maze IV?
Dr Lawrance. Thank you again for the excellent question.
That is a difficult question to answer given our institutional
experience with the Cox maze IV procedure. We have performed
a preliminary analysis looking at crossclamp times and cardio-
pulmonary bypass times comparing patients at the beginning of
the study period to patients at the end of the study period and found
that there was no difference. However, because the morbidity was962 The Journal of Thoracic and Cardiovascular Surglow in both groups and we had no mortality in our right minithor-
acotomy group, the study was not powered to compare early
complication rates between patients at the beginning and end of
the study period. Therefore, it is difficult to discuss a learning
curve.
In addition, most of these cases at our center were performed by
1 surgeon, who is an expert in the Cox maze IV procedure and
had been performing a right minithoracotomy approach for
mitral valve procedures several years before the beginning of
the study period. So it is unlikely that a learning curve
established from this study would really translate well to other
institutions.
Dr Richard Lee (St Louis, Mo). I have no disclosures. I
congratulate you on a very nice study and a very nice presentation.
Our group has previously done a comparison of a classic maze
versus a hybrid approach using a different lesion set. We found,
however, even in the classic maze group therewas a 10% incidence
of subsequent late catheter ablation; in addition, there were many
more subsequent cardioversions. Did you look at the number of
cardioversions and/or catheter ablations in both groups after a
procedure, and if so, how were those data managed?
Dr Lawrance. Thank you Dr Lee for the question. We did not
specifically look at those data during this study. However, we do
have that data available in our database and will be able to provide
that to you in the near future.ery c September 2014
